Auto Shanghai 2023 ushers in a new era of intelligent vehicles! Nearly 20 mass-produced models equipped with RoboSense LiDAR
RoboSense, a world-leading provider of Smart LiDAR Sensor Systems, announced today its M series LiDAR products, which assisted more than 10 well-known global automakers showcase nearly 20 intelligent vehicle models at the 20th Shanghai International Automobile Industry Exhibition 2023 (referred to as the Auto Shanghai 2023), presenting the excellent performance of their intelligent driving assistance systems to the audience.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230428005133/en/
Part of EV models equipped with RoboSense LiDAR showcased at Auto Shanghai 2023 (Photo: Business Wire)
This year's Shanghai Auto Show brought more than 1,000 exhibitors, including well-known global car companies, independent domestic car brands, new car-making forces, and automobile technology companies, using 13 indoor exhibition halls.
The M series sensors were the first LiDAR in the world to achieve automotive-grade mass production. It uses a patented revolutionary chip-based 2D scanning solution that boasts supreme performance and reliability.
According to the statistics obtained by industry media, “there are 38 models equipped with LiDARs at Auto Shanghai 2023, of which RoboSense is the biggest winner, being the LiDAR supplier of 18 of them”，the brands including SAIC IM, BYD, XPeng, FAW Hongqi, GWM WEY, Chery Exeed, Geely, GAC Hyper, Lotus, etc. To date, RoboSense has earned design wins for mass production of LiDAR products for over 50 vehicle models with 18 automakers.
As the theme of this auto show, "Embracing the New Era of the Automobile Industry," the global automobile industry is accelerating its transformation and upgrading towards electrification and intelligence. Against this backdrop, this year's Shanghai Auto Show is not only a concentrated display of product strength for the global automobile industry's intelligent transformation and upgrading, but also strong evidence of RoboSense's efforts to accelerate the intelligent development of the automobile industry.
RoboSense has invested heavily in building world-class product development and testing capabilities, while expanding its global footprint with operational headquarters in both Europe and the US. Its capabilities include intelligent manufacturing system in Southern China, along with the world’s first and only certified accreditation automotive-grade LiDAR laboratory, its China National Accreditation Service (CNAS) certified LiDAR lab, with more than 200 advanced pieces of testing equipment.
RoboSense's M series LiDAR technology has played a significant role in the intelligent transformation of the automobile industry, and the 2023 Shanghai Auto Show has demonstrated the excellent performance of intelligent driving assistance systems, showcasing the industry's progress towards electrification and intelligence.
About RoboSense (www.robosense.ai):
RoboSense (Suteng Innovation Technology Co., Ltd.) is a world-leading provider of Smart LiDAR Sensor Systems. Comprising LiDAR sensors, AI algorithms and IC chipsets, its portfolio transforms conventional 3D LiDAR sensors with comprehensive data analysis and interpretation systems.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230428005133/en/
Contact information
Grace Ye
media@robosense.ai
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IQM and Scientek Corporation Sign Reseller Agreement to Boost Quantum Computing in Taiwan18.9.2025 11:11:00 EEST | Press release
IQM Quantum Computers and Scientek Corporation, a Taiwan-based reseller of scientific instruments and other high-technology products, today announced the signing of a strategic reseller agreement to accelerate the commercialisation of quantum computing. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918110284/en/ IQM and Scientek Corporation sign reseller agreement The agreement follows the installation of IQM Spark, the first full-stack superconducting quantum computer at the Taiwan Semiconductor Research Institute (TSRI). Under the reseller agreement, Scientek will sell and promote IQM’s on-premises quantum computers and cloud solutions that meet the evolving needs of universities, research institutions, and enterprises. Combining Scientek's strong market presence and customer-centric approach in Taiwan with IQM’s quantum leadership, the collaboration will help Taiwanese businesses and research institutions to explore a
Acuity Knowledge Partners Acquires Ascent18.9.2025 10:30:00 EEST | Press release
Acuity Knowledge Partners (Acuity), a leading global provider of bespoke research, data management, analytics and AI solutions to the financial services sector, has announced that it has exchanged on the acquisition of Ascent. The transaction is expected to close on 30th September 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250915732380/en/ L-R: Stewart Smythe, Chief Executive Officer, Ascent; Jon O'Donnell, Chief Operating Officer, Acuity Knowledge Partners, and Robert King, Chief Executive Officer, Acuity Knowledge Partners This strategic move significantly expands Acuity's Data and Technology Services (DTS) division and its offering of technology and AI led services and solutions. Ascent, a leading European provider of AI-powered digital transformation services, supports over 170 clients globally, with 550 data, software, and cloud specialists operating across seven European jurisdictions. “Our acquisition of Asc
Almirall Presents Long‑Term Results from First Real‑World Dermatology Study Using WHO‑5 Well‑Being Index as Primary Endpoint in the treatment of Psoriasis at EADV 202518.9.2025 09:00:00 EEST | Press release
Almirall, S.A. (ALM) a global biopharmaceutical company focused on medical dermatology today announced new long-term results from the POSITIVE study, presented as a late-breaker at the 34th Congress of the European Academy of Dermatology and Venereology 2025 (EADV) in Paris. POSITIVE is the first RWE study in dermatology to use the World Health Organization Well-Being Index (WHO-5) as a primary endpoint. The selection of the abstract as a late breaker at the EADV congress highlights the importance of the findings of the POSITIVE study and its unique approach to evaluating the long-term holistic impact of an advanced treatment in patients with moderate-to-severe psoriasis, a condition that profoundly impairs social, psychological, and physical quality of life, impacting overall well-being1. Two‑Year Real‑World Results from POSITIVE The 24-month, multinational, phase IV observational study enrolled 785 adult patients with moderate-to-severe plaque psoriasis across nine European countries
Shield and PwC UK Forge Strategic Collaboration to Deliver Future-Ready Communications Compliance18.9.2025 09:00:00 EEST | Press release
Shield, a leading AI platform for digital communication governance and archiving, today announced a collaboration with PwC UK, one of the world’s most trusted professional services firms. The alliance brings together Shield’s unified, cloud-native solution with PwC’s specialist expertise in communications surveillance delivery, regulatory compliance and complex programme execution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250917394739/en/ Shield and PwC launch a strategic collaboration to modernize eComms surveillance with AI-driven compliance solutions for financial institutions. The collaboration is designed to support institutions as they modernise their approach to communications monitoring, helping them implement an advanced and proactive risk management approach at scale and with confidence. This joint offering provides an end-to-end solution designed to meet evolving regulatory expectations, accelerate adoption
Curatis: FDA Minutes Confirm Positive Outcome of Meeting on 9. September 2025 – Corticorelin on Track for Phase 318.9.2025 08:00:00 EEST | Press release
Curatis Holding AG (SIX:CURN) received the official minutes from the FDA meeting which took place on 9. September. Based on the totality of the feedback and discussions, Curatis can proceed as planned with the clinical development of corticorelin. Corticorelin is under development as a novel treatment intended to reduce or even eliminate steroid use and associated toxicities thereby potentially impacting the quality of life of patients suffering from peritumoral brain edema (PTBE) associated with metastatic (secondary) brain tumors. The virtual meeting with the FDA provided the opportunity to discuss the clinical development plan for corticorelin and encompassed CMC (Chemistry, Manufacturing and Control), nonclinical and clinical aspects. The offical FDA minutes which Curatis received after publication of the half year results reflect the positive outcome. Curatis may proceed without delay to a regulatory submission supporting a pivotal study in patients suffering from PTBE secondary t
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom